Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.journals.uchicago.edu/CID/journal/issues/v36n3/21154/brief/21154.abstract.html

Clinical Infectious Diseases    2003;36:275-280
© 2003 by the Infectious Diseases Society of America. All rights reserved.
1058-4838/2003/3603-0005$15.00

 


Go to full text | Return to Issue Table of Contents

 

MAJOR ARTICLE

Chronic Hepatitis C Virus Infection in Childhood: Clinical Patterns and Evolution in 224 White Children

Paloma Jara,1 Massimo Resti,2 Loreto Hierro,1 Raffaella Giacchino,3 Cristiana Barbera,4 Lucia Zancan,6 Carlo Crivellaro,5 Etienne Sokal,9 Chiara Azzari,2 Maria Guido,7 and Flavia Bortolotti8

1Hospital Infantil La Paz, Madrid, Spain; 2Clinica Pediatrica 3, Hospital Meier, Florence, 3Department of Infectious Diseases, Istituto Gaslini, Genoa, 4Clinica Pediatrica, Turin, 5Department of Pediatrics, Chioggia, 6Department of Pediatrics, 7Istituto Anatomia Patologica, and 8Clinica Medica 5, University of Padua, Padua, Italy; and 9Hospital St. Luc, Brussels, Belgium

 

Received 9 August 2002; accepted 20 October 2002; electronically published 14 January 2003.

The characteristics and evolution of hepatitis C virus (HCV) infection were retrospectively investigated in a study of 224 HCV RNA–seropositive white children who were consecutively recruited at 7 European centers in 1980–1998. At presentation, all patients were positive for antibodies to hepatitis C virus, 87% were asymptomatic, and 48% had alanine aminotransferase (ALT) levels that were &les;2 times the upper limit of the range considered to be normal. Of 200 children followed for 1–17.5 years (mean follow-up ± standard deviation [SD], 6.2 ± 4.7 years), only 12 (6%) achieved sustained viremia clearance and normalization of the ALT level. In 92 revised liver biopsy specimen analyses, the mean fibrosis score (±SD) was 1.5 ± 1.3 for children <15 years of age and 2.3 ± 1.2 for children &ges;15 years of age (range, 0–6 years; P < .01). Pediatric HCV infection is usually mild, but few patients, especially those who are perinatally infected, clear viremia in the medium-term follow-up. Conversely, the higher rates of fibrosis observed in older patients suggest the possibility of an insidious progression of HCV-associated liver disease.

 


Go to full text | Return to Issue Table of Contents

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.